Arch Microbiol 2009, 191:895–902.PubMedCrossRef 32. Ohtani K, Hirakawa H, Tashiro K, Yoshizawa S, Kuhara S, Shimizu T: Identification of a two-component VirR/VirS regulon in Clostridium perfringens . Anaerobe 2010,

16:258–264.PubMedCrossRef 33. O’Brien DK, Foretinib concentration Melville SB: Effects of Clostridium perfringens alpha-toxin (PLC) and perfringolysin O (PFO) on cytotoxicity to macrophages, on escape from the phagosomes of macrophages, and on persistence of C. perfringens in host tissues. Infect Immun 2004, 72:5204–5215.PubMedCrossRef 34. Awad MM, Ellemor DM, Bryant AE, Matsushita O, Boyd RL, Stevens DL: Construction and virulence testing of a collagenase mutant of Clostridium perfringens . Microb Pathog 2000, 28:107–117.PubMedCrossRef 35. Dargatz H, Diefenthal T, Witte V, Reipen G, von Wettstein D: The heterodimeric protease clostripain from Clostridium histolyticum is encoded by a single gene. Mol Gen Genet 1993, 240:140–145.PubMedCrossRef 36. Li J, Sayeed S, Robertson S, Chen J, McClane BA: Sialidases affect the host cell adherence and epsilon toxin-induced cytotoxicity of Clostridium perfringens type D strain CN3718. PLoS Pathog 2011,

7:e1002429.PubMedCrossRef 37. Song JM, Im JH, Hoon JH, Kang JD, Kang DJ: A simple method for hyaluronic acid Selumetinib in vitro quantification in culture broth. Carbohydr Polym 2009, selleckchem 78:633–634.CrossRef 38. Kugelberg E, Lofmark S, Wretlind B, Andersson DI: Reduction of the fitness burden Aprepitant of quinolone resistance in Pseudomonas aeruginosa . J Antimicrob Chemother 2005, 55:22–30.PubMedCrossRef 39. Marcusson LL, Frimodt-Moller N, Hughes

D: Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathog 2009, 5:e1000541.PubMedCrossRef 40. Bachoual R, Tankovic J, Soussy CJ: Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli . Microb Drug Resist 1998, 4:271–276.PubMedCrossRef 41. Smani Y, Lopez-Rojas R, Dominguez-Herrera J, Docobo-Perez F, Marti S, Vila J: In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii. Clin Microbiol Infect 2012, 18:1–4.CrossRef 42. Shimizu T, Shima K, Yoshino K, Yonezawa K, Hayashi H: P roteome and transcriptome analysis of the virulence genes regulated by the VirR/VirS system in Clostridium perfringens . J Bacteriol 2002, 184:2587–2594.PubMedCrossRef 43. Shimizu T, Yaguchi H, Ohtani K, Banu S, Hayashi H: Clostridial VirR/VirS regulon involves a regulatory RNA molecule for expression of toxins. Mol Microbiol 2002, 43:257–265.PubMedCrossRef 44. Okumura K, Ohtani K, Hayashi H, Shimizu T: Characterization of genes regulated directly by the VirR/VirS system in Clostridium perfringens . J Bacteriol 2008, 190:7719–7727.PubMedCrossRef 45.